文献速递神经PETMRCT

血浆胶质纤维酸性蛋白和磷酸化Tau 181与18F-SynVesT-1脑PET显像突触前密度依赖性Tau病理的相关性

Plasma Glial Fibrillary Acid Protein and Phosphorated Tau 181 Association with Presynaptic Density-Dependent Tau Pathology at 18F-SynVesT-1 Brain PET Imaging.
PubMed 文献 · Radiology · 2024-01-01

前瞻性纳入50名认知正常者和70名认知障碍者,用18F-SynVesT-1 PET/MRI测突触密度,分析其与血浆及血清标志物的关系。血浆p-tau-181和GFAP升高与全脑皮质和海马突触密度降低相关,控制tau PET后关联消失,提示该关系主要受tau蓄积影响而非Aβ沉积或皮质厚度。

要点

  • 血浆p-tau-181和GFAP升高与18F-SynVesT-1 PET/MRI所测全脑皮质和海马突触密度降低相关。
  • 控制血浆Aβ42/40比值、Aβ PET或皮质厚度后,上述关联仍存在(P值范围<.001-.01)。
  • 控制tau PET后关联消失(P值范围.08-.83),提示关系主要受tau蓄积影响。

核心结论

  • 血浆p-tau-181和GFAP与18F-SynVesT-1 PET/MRI测量的突触密度密切相关,该关系主要受tau蓄积影响,而非Aβ沉积或皮质厚度。

研究设计与样本

  • Aβ和tau分别用18F-florbetapir和18F-MK6240 PET/CT评估,突触密度用18F-SynVesT-1 PET/MRI评估;采用Pearson相关、线性回归和中介分析。

诊断标准与关键数值

  • 控制tau PET后,上述关联消失(P值范围.08-.83)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Synaptic loss is an important factor in Alzheimer disease (AD); however, blood assays that conveniently and rapidly reflect changes in synaptic density are lacking. Purpose To correlate multiple potential synaptic blood markers with synaptic density measured using 18F-SynVesT-1, a fluorine 18 (18F)-labeled radiotracer, brain PET and to explore the independent associations between these markers and synaptic density. Materials and Methods This prospective study included 50 cognitively unimpaired (mean age, 65.0 years ± 8.3 [SD]; 37 female) participants and 70 participants with cognitive impairment (mean age, 69.5 years ± 7.9; 43 female) from the Memory Clinic of Shanghai Jiao Tong University Affiliated Ruijin Hospital and communities in Shanghai. Amyloid-β (Aβ) and tau were assessed using 18F-florbetapir and 18F-MK6240 PET/CT. Synaptic density was evaluated with 18F-SynVesT-1 PET/MRI. Pearson correlation analysis was used to investigate relationships of plasma (Aβ42/40 ratio, phosphorylated tau 181 [p-tau-181], glial fibrillary acid protein [GFAP], neurofilament light) and serum (C-reactive protein, tumor necrosis factor-α, α-synuclein, neurogranin, active plasminogen activator inhibitor-1, tissue plasminogen activator) biomarkers with synaptic density. Linear regression models and mediation analysis were used to explore effects of other AD-related pathologies on these relationships. Results Correlations were observed between increased p-tau-181 and GFAP and decreased synaptic density in global cortex (rp-tau-181 = -0.352, rGFAP = -0.386; both P < .001) and hippocampus (rp-tau-181 = -0.361, rGFAP = -0.369; both P < .001) at 18F-SynVesT-1 PET/MRI. The relationships between p-tau-181 and GFAP with 18F-SynVesT-1 PET/MRI persisted after controlling for plasma Aβ42/40 ratio, Aβ PET, or cortical thickness (P value range, <.001-.01). This association disappeared after controlling for tau PET (P value range, .08-.83). Conclusion Plasma p-tau-181 and GFAP are closely associated with synaptic density measured using 18F-SynVesT-1 PET/MRI, with the relationship primarily influenced by tau accumulation rather than Aβ deposition or cortical thickness. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Giannakopoulos in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Wu J, Li B, Wang J, et al. Plasma Glial Fibrillary Acid Protein and Phosphorated Tau 181 Association with Presynaptic Density-Dependent Tau Pathology at 18F-SynVesT-1 Brain PET Imaging. Radiology. 2024. PMID: 39560478. doi:10.1148/radiol.233019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。